Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZBxNZW)F1 mice | Zendy

M. Ángeles Ramos | Zendy; Celestino Piñera | Zendy; Ma ÁNgeles Setien | Zendy; Luis Buelta | Zendy; Ma.A. de Cos | Zendy; Ángel Francisco | Zendy; Ramón Merino | Zendy; M. Arias | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZBxNZW)F1 mice

Author(s) -

M. Ángeles Ramos,

Celestino Piñera,

Ma ÁNgeles Setien,

Luis Buelta,

Ma.A. de Cos,

Ángel Francisco,

Ramón Merino,

M. Arias

Publication year - 2003

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfg034

Subject(s) - mycophenolate , medicine , autoantibody , autoimmunity , immunology , mycophenolic acid , systemic lupus erythematosus , lupus erythematosus , immune system , transplantation , disease , antibody

Mycophenolate mofetil (MMF) has been successfully used to improve or prevent the development of systemic lupus erythematosus (SLE) in both humans and in several lupus-prone mice. In the present study, we evaluated mechanisms through which MMF may exert its therapeutic effect on the development of systemic autoimmunity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research